Evidence map›Paper›PMID 33112547›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2020

New Hepatic Resection Criteria for Intermediate-Stage Hepatocellular Carcinoma Can Improve Long-Term Survival: A Retrospective, Multicenter Collaborative Study.

Hiroya Iida, Masaki Kaibori, Fumitoshi Hirokawa, Yoshihiro Inoue, Masaki Ueno, Kousuke Matsui, Morihiko Ishizaki, Shogo Tanaka, Shigekazu Takemura, Takeo Nomi and 8 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Hiroya IidaDepartment of Surgery, Shiga University of Medical Science, Otsu, Japan.
Masaki KaiboriDepartment of Surgery, Kansai Medical University, Hirakata, Japan.
Fumitoshi HirokawaDepartment of General and Gastroenterological Surgery, Osaka Medical College, Takatsuki, Japan.
Yoshihiro InoueDepartment of General and Gastroenterological Surgery, Osaka Medical College, Takatsuki, Japan.
Masaki UenoSecond Department of Surgery, Wakayama Medical University, Wakayama, Japan.
Kousuke MatsuiDepartment of Surgery, Kansai Medical University, Hirakata, Japan.
Morihiko IshizakiDepartment of Surgery, Kansai Medical University, Hirakata, Japan.
Shogo TanakaDepartment of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Shigekazu TakemuraDepartment of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Takeo NomiDepartment of Surgery, Nara Medical University, Kashihara, Japan.
Daisuke HokutouDepartment of Surgery, Nara Medical University, Kashihara, Japan.
Takehiro NodaDepartment of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.
Hidetoshi EguchiDepartment of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.
Takuya NakaiDepartment of Surgery, Faculty of Medicine, Kinki University, Osaka-sasayama, Japan.
Hiromitsu MaehiraDepartment of Surgery, Shiga University of Medical Science, Otsu, Japan.
Haruki MoriDepartment of Surgery, Shiga University of Medical Science, Otsu, Japan.
Masaji TaniDepartment of Surgery, Shiga University of Medical Science, Otsu, Japan.
Shoji KuboDepartment of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatic resection (HR) is not recommended for intermediate-stage hepatocellular carcinoma (HCC) by the Barcelona Clinic Liver Cancer criteria. We examined the prognostic factors of HR for intermediate-stage HCC and developed new HR criteria for intermediate-stage HCC.

methodsA total of 110 patients who underwent HR without any prior treatment for intermediate-stage HCC between January 2007 and December 2012 were enrolled at eight university hospitals. The outcomes and prognostic factors of HR were evaluated to develop new HR criteria.

resultsIn terms of tumor size and number, the most significant prognostic factors were within the up-to-seven criteria. Furthermore, serum albumin level ≥35 g/L and serum alpha-fetoprotein (AFP) level.

Indexed as

AgedCarcinoma, HepatocellularFemaleFollow-Up StudiesHepatectomyHumansLiver NeoplasmsMalePrognosisRetrospective StudiesSurvival RateBCLC stage BhepatectomyHepatic resectionHepatocellular carcinomaIntermediate stage

Identifiers

PMID33112547
PMCPMC7798158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.